Vanillins–a novel family of DNA-PK inhibitors. Durant, S. & Karran, P. Nucleic Acids Research, 31(19):5501–5512, October, 2003. abstract bibtex Non-homologous DNA end-joining (NHEJ) is a major pathway of double strand break (DSB) repair in human cells. Here we show that vanillin (3-methoxy-4-hydroxybenzaldehyde)–a naturally occurring food component and an acknowledged antimutagen, anticlastogen and anticarcinogen–is an inhibitor of NHEJ. Vanillin blocked DNA end-joining by human cell extracts by directly inhibiting the activity of DNA-PK, a crucial NHEJ component. Inhibition was selective and vanillin had no detectable effect on other steps of the NHEJ process, on an unrelated protein kinase or on DNA mismatch repair by cell extracts. Subtoxic concentrations of vanillin did not affect the ATM/ATR-dependent phosphorylation of Chk2 or the S-phase checkpoint response after ionising radiation. They significantly potentiated the cytotoxicity of cisplatin, but did not affect sensitivity to UVC. A limited screen of structurally related compounds identified two substituted vanillin derivatives that were 100- and 50-fold more potent than vanillin as DNA-PK inhibitors. These compounds also sensitised cells to cisplatin. The inhibition of NHEJ is consistent with the antimutagenic and other biological properties of vanillin, possibly altering the balance between DSB repair by NHEJ and homologous recombination.
@article{durant_vanillins--novel_2003,
title = {Vanillins--a novel family of {DNA}-{PK} inhibitors},
volume = {31},
issn = {1362-4962},
abstract = {Non-homologous DNA end-joining (NHEJ) is a major pathway of double strand break (DSB) repair in human cells. Here we show that vanillin (3-methoxy-4-hydroxybenzaldehyde)--a naturally occurring food component and an acknowledged antimutagen, anticlastogen and anticarcinogen--is an inhibitor of NHEJ. Vanillin blocked DNA end-joining by human cell extracts by directly inhibiting the activity of DNA-PK, a crucial NHEJ component. Inhibition was selective and vanillin had no detectable effect on other steps of the NHEJ process, on an unrelated protein kinase or on DNA mismatch repair by cell extracts. Subtoxic concentrations of vanillin did not affect the ATM/ATR-dependent phosphorylation of Chk2 or the S-phase checkpoint response after ionising radiation. They significantly potentiated the cytotoxicity of cisplatin, but did not affect sensitivity to UVC. A limited screen of structurally related compounds identified two substituted vanillin derivatives that were 100- and 50-fold more potent than vanillin as DNA-PK inhibitors. These compounds also sensitised cells to cisplatin. The inhibition of NHEJ is consistent with the antimutagenic and other biological properties of vanillin, possibly altering the balance between DSB repair by NHEJ and homologous recombination.},
language = {eng},
number = {19},
journal = {Nucleic Acids Research},
author = {Durant, Stephen and Karran, Peter},
month = oct,
year = {2003},
keywords = {Antimutagenic Agents, Antineoplastic Agents, Benzaldehydes, Cell Line, Cisplatin, DNA Repair, DNA-Activated Protein Kinase, DNA-Binding Proteins, Drug Synergism, Enzyme Inhibitors, Humans, Nuclear Proteins, Protein Kinases, Protein-Serine-Threonine Kinases, Rad51 Recombinase, Recombination, Genetic, Tumor Cells, Cultured},
pages = {5501--5512},
}
Downloads: 0
{"_id":"5kPztdSs4wwzZ2YCF","bibbaseid":"durant-karran-vanillinsanovelfamilyofdnapkinhibitors-2003","author_short":["Durant, S.","Karran, P."],"bibdata":{"bibtype":"article","type":"article","title":"Vanillins–a novel family of DNA-PK inhibitors","volume":"31","issn":"1362-4962","abstract":"Non-homologous DNA end-joining (NHEJ) is a major pathway of double strand break (DSB) repair in human cells. Here we show that vanillin (3-methoxy-4-hydroxybenzaldehyde)–a naturally occurring food component and an acknowledged antimutagen, anticlastogen and anticarcinogen–is an inhibitor of NHEJ. Vanillin blocked DNA end-joining by human cell extracts by directly inhibiting the activity of DNA-PK, a crucial NHEJ component. Inhibition was selective and vanillin had no detectable effect on other steps of the NHEJ process, on an unrelated protein kinase or on DNA mismatch repair by cell extracts. Subtoxic concentrations of vanillin did not affect the ATM/ATR-dependent phosphorylation of Chk2 or the S-phase checkpoint response after ionising radiation. They significantly potentiated the cytotoxicity of cisplatin, but did not affect sensitivity to UVC. A limited screen of structurally related compounds identified two substituted vanillin derivatives that were 100- and 50-fold more potent than vanillin as DNA-PK inhibitors. These compounds also sensitised cells to cisplatin. The inhibition of NHEJ is consistent with the antimutagenic and other biological properties of vanillin, possibly altering the balance between DSB repair by NHEJ and homologous recombination.","language":"eng","number":"19","journal":"Nucleic Acids Research","author":[{"propositions":[],"lastnames":["Durant"],"firstnames":["Stephen"],"suffixes":[]},{"propositions":[],"lastnames":["Karran"],"firstnames":["Peter"],"suffixes":[]}],"month":"October","year":"2003","keywords":"Antimutagenic Agents, Antineoplastic Agents, Benzaldehydes, Cell Line, Cisplatin, DNA Repair, DNA-Activated Protein Kinase, DNA-Binding Proteins, Drug Synergism, Enzyme Inhibitors, Humans, Nuclear Proteins, Protein Kinases, Protein-Serine-Threonine Kinases, Rad51 Recombinase, Recombination, Genetic, Tumor Cells, Cultured","pages":"5501–5512","bibtex":"@article{durant_vanillins--novel_2003,\n\ttitle = {Vanillins--a novel family of {DNA}-{PK} inhibitors},\n\tvolume = {31},\n\tissn = {1362-4962},\n\tabstract = {Non-homologous DNA end-joining (NHEJ) is a major pathway of double strand break (DSB) repair in human cells. Here we show that vanillin (3-methoxy-4-hydroxybenzaldehyde)--a naturally occurring food component and an acknowledged antimutagen, anticlastogen and anticarcinogen--is an inhibitor of NHEJ. Vanillin blocked DNA end-joining by human cell extracts by directly inhibiting the activity of DNA-PK, a crucial NHEJ component. Inhibition was selective and vanillin had no detectable effect on other steps of the NHEJ process, on an unrelated protein kinase or on DNA mismatch repair by cell extracts. Subtoxic concentrations of vanillin did not affect the ATM/ATR-dependent phosphorylation of Chk2 or the S-phase checkpoint response after ionising radiation. They significantly potentiated the cytotoxicity of cisplatin, but did not affect sensitivity to UVC. A limited screen of structurally related compounds identified two substituted vanillin derivatives that were 100- and 50-fold more potent than vanillin as DNA-PK inhibitors. These compounds also sensitised cells to cisplatin. The inhibition of NHEJ is consistent with the antimutagenic and other biological properties of vanillin, possibly altering the balance between DSB repair by NHEJ and homologous recombination.},\n\tlanguage = {eng},\n\tnumber = {19},\n\tjournal = {Nucleic Acids Research},\n\tauthor = {Durant, Stephen and Karran, Peter},\n\tmonth = oct,\n\tyear = {2003},\n\tkeywords = {Antimutagenic Agents, Antineoplastic Agents, Benzaldehydes, Cell Line, Cisplatin, DNA Repair, DNA-Activated Protein Kinase, DNA-Binding Proteins, Drug Synergism, Enzyme Inhibitors, Humans, Nuclear Proteins, Protein Kinases, Protein-Serine-Threonine Kinases, Rad51 Recombinase, Recombination, Genetic, Tumor Cells, Cultured},\n\tpages = {5501--5512},\n}\n\n","author_short":["Durant, S.","Karran, P."],"key":"durant_vanillins--novel_2003","id":"durant_vanillins--novel_2003","bibbaseid":"durant-karran-vanillinsanovelfamilyofdnapkinhibitors-2003","role":"author","urls":{},"keyword":["Antimutagenic Agents","Antineoplastic Agents","Benzaldehydes","Cell Line","Cisplatin","DNA Repair","DNA-Activated Protein Kinase","DNA-Binding Proteins","Drug Synergism","Enzyme Inhibitors","Humans","Nuclear Proteins","Protein Kinases","Protein-Serine-Threonine Kinases","Rad51 Recombinase","Recombination","Genetic","Tumor Cells","Cultured"],"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://bibbase.org/zotero/tplas","dataSources":["YLgywGcXWx96vKKaB"],"keywords":["antimutagenic agents","antineoplastic agents","benzaldehydes","cell line","cisplatin","dna repair","dna-activated protein kinase","dna-binding proteins","drug synergism","enzyme inhibitors","humans","nuclear proteins","protein kinases","protein-serine-threonine kinases","rad51 recombinase","recombination","genetic","tumor cells","cultured"],"search_terms":["vanillins","novel","family","dna","inhibitors","durant","karran"],"title":"Vanillins–a novel family of DNA-PK inhibitors","year":2003}